Zhenzhen Huang Selected Research

perfluoro-n-nonanoic acid

8/2021	Association between maternal exposure to perfluoroalkyl and polyfluoroalkyl substances and risks of adverse pregnancy outcomes: A systematic review and meta-analysis.
12/2020	Exposure to perfluoroalkyl substances and allergic outcomes in children: A systematic review and meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhenzhen Huang Research Topics

Disease

7	Neoplasms (Cancer) 06/2022 - 03/2011
2	Urinary Bladder Neoplasms (Bladder Cancer) 06/2022 - 10/2011
2	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 12/2020
1	Tetanus 08/2022
1	Mumps 08/2022
1	Measles 08/2022
1	Human Influenza (Influenza) 08/2022
1	Infections 08/2022
1	Rubella (German Measles) 08/2022
1	Simpson-Golabi-Behmel syndrome 05/2022
1	Pediatric Obesity 05/2022
1	Prostatic Neoplasms (Prostate Cancer) 02/2022
1	Hypertrophy 01/2022
1	Spontaneous Abortion (Miscarriage) 08/2021
1	Premature Birth (Birth, Premature) 08/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2020
1	Liver Neoplasms (Liver Cancer) 12/2020
1	Eczema 12/2020
1	Allergic Rhinitis 12/2020
1	Atopic Dermatitis (Atopic Eczema) 12/2020
1	Bacterial Infections (Bacterial Infection) 10/2020
1	Dysbiosis 01/2020
1	Inflammation (Inflammations) 01/2020
1	Body Weight (Weight, Body) 01/2019
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019
1	Multiple Myeloma 03/2016
1	Peripheral Nervous System Diseases (PNS Diseases) 03/2016
1	Hematologic Neoplasms (Hematological Malignancy) 03/2016
1	Hyperalgesia 03/2016
1	Infertility (Sterility) 07/2014
1	Oligospermia (Oligozoospermia) 07/2014
1	Alcoholism (Alcohol Abuse) 03/2014
1	Urogenital Neoplasms 08/2012
1	Renal Cell Carcinoma (Grawitz Tumor) 03/2011

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 07/2014 - 03/2011
2	perfluorooctanoic acidIBA 08/2022 - 12/2020
2	Conditioned Culture MediaIBA 05/2022 - 01/2022
2	Insulin (Novolin)FDA Link 01/2022 - 01/2019
2	perfluorooctane sulfonic acidIBA 08/2021 - 12/2020
2	perfluoro-n-nonanoic acidIBA 08/2021 - 12/2020
2	CopperIBA 06/2020 - 03/2020
2	Cysteamine (Mercaptamine)FDA Link 06/2020 - 03/2020
2	AntioxidantsIBA 07/2014 - 03/2014
1	perflexane (perfluorohexane)FDA Link 08/2022
1	perfluorohexanesulfonic acidIBA 08/2022
1	VaccinesIBA 08/2022
1	U 0126 (UO 126)IBA 06/2022
1	esculetinIBA 06/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2022
1	MicroRNAs (MicroRNA)IBA 05/2022
1	CytokinesIBA 05/2022
1	Indicators and Reagents (Reagents)IBA 02/2022
1	SAR131675IBA 01/2022
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2022
1	Reelin ProteinIBA 01/2022
1	D-Aspartic Acid (D Aspartate)IBA 01/2022
1	CCAAT-Enhancer-Binding Protein-betaIBA 01/2022
1	Glutamic Acid (Glutamate)FDA Link 01/2022
1	ButyrylcholinesteraseIBA 01/2022
1	Trans-Activators (Trans-Acting Factor)IBA 01/2022
1	Glutathione (Reduced Glutathione)IBA 12/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2020
1	Hydroxyl RadicalIBA 03/2020
1	Bile Acids and Salts (Bile Acids)IBA 01/2020
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2019
1	Collagen Type IV (Type IV Collagen)IBA 01/2019
1	Urea (Carbamide)FDA LinkGeneric 01/2019
1	Matrix Metalloproteinases (MMPs)IBA 01/2019
1	CreatinineIBA 01/2019
1	Blood Glucose (Blood Sugar)IBA 01/2019
1	Ramipril (Altace)FDA LinkGeneric 01/2019
1	NitrogenIBA 01/2019
1	Fibronectins (Fibronectin)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Pharmaceutical PreparationsIBA 03/2016
1	Bortezomib (Velcade)FDA Link 03/2016
1	Neutralizing AntibodiesIBA 03/2016
1	CurcuminIBA 03/2014
1	Peroxidase (Myeloperoxidase)IBA 05/2013
1	graphene oxideIBA 05/2013
1	GoldIBA 05/2013
1	EnzymesIBA 05/2013

Therapy/Procedure

1	Radiotherapy 06/2020
1	Therapeutics 01/2015